Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Lehrer-Graiwer Joshua, Chief Executive Officer. Insider active across 1 company, notably Graphite Bio, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 16 January 2021. The latest transaction was filed on 16 January 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Joshua Lehrer-Graiwer is President and Chief Executive Officer of Graphite Bio, Inc. He is responsible for the strategic and operational direction of the company. With a strong background in the biopharmaceutical sector, he guides Graphite Bio in its commitment to developing innovative gene therapies for genetic diseases.